It is active in the field of using specialized histopathological methods to evaluate the safety and efficacy of new therapeutic methods of drugs and devices at the level of experimental animal models. In addition, it is active in the development of new experimental animal models for eye diseases and develops new methods for the evaluation of vision mechanisms and pathologies at the cellular and molecular level. Finally, it promotes the creation of genetic databases for hereditary eye diseases.